| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 437.30M | 420.40M | 400.00M | 317.60M | 268.60M |
| Gross Profit | 176.80M | 164.30M | 154.20M | 128.10M | 118.60M |
| EBITDA | 72.90M | 65.90M | 63.80M | 55.70M | 53.80M |
| Net Income | 47.10M | 39.70M | 38.50M | 33.90M | 27.80M |
Balance Sheet | |||||
| Total Assets | 514.20M | 432.90M | 401.70M | 377.50M | 336.30M |
| Cash, Cash Equivalents and Short-Term Investments | 81.60M | 64.80M | 53.60M | 53.60M | 68.70M |
| Total Debt | 48.00M | 4.60M | 4.90M | 5.80M | 4.40M |
| Total Liabilities | 168.60M | 115.30M | 109.00M | 108.70M | 88.10M |
| Stockholders Equity | 338.00M | 317.60M | 292.70M | 268.80M | 244.50M |
Cash Flow | |||||
| Free Cash Flow | 22.10M | 29.10M | 30.70M | 21.30M | 38.40M |
| Operating Cash Flow | 52.50M | 48.30M | 48.50M | 35.90M | 43.40M |
| Investing Cash Flow | -25.10M | -39.30M | -8.10M | -71.50M | -9.00M |
| Financing Cash Flow | 12.60M | -21.20M | -19.70M | -20.20M | -15.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £685.29M | 9.21 | 14.27% | 2.74% | 4.02% | 18.51% | |
75 Outperform | £15.49B | 8.53 | 26.03% | 1.96% | 9.27% | 16.35% | |
72 Outperform | £345.87M | 6.75 | 23.59% | 3.39% | 1.30% | 20.13% | |
65 Neutral | £414.01M | 9.36 | 3.73% | 4.05% | -2.21% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | £142.19M | -26.80 | -1.06% | 5.22% | 2.21% | -0.51% | |
57 Neutral | £924.38M | 16.71 | 9.32% | 2.11% | -11.80% | -8.61% |